ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,292 | +124.1% | 406 | +153.8% | 0.00% | – |
| Q2 2023 | $3,254 | -42.0% | 160 | -38.0% | 0.00% | – |
| Q1 2023 | $5,614 | -45.4% | 258 | -22.3% | 0.00% | – |
| Q4 2022 | $10,289 | -20.9% | 332 | -33.7% | 0.00% | – |
| Q3 2022 | $13,000 | +8.3% | 501 | -14.1% | 0.00% | – |
| Q2 2022 | $12,000 | +71.4% | 583 | +102.4% | 0.00% | – |
| Q1 2022 | $7,000 | -46.2% | 288 | -23.2% | 0.00% | – |
| Q4 2021 | $13,000 | +62.5% | 375 | +33.5% | 0.00% | – |
| Q3 2021 | $8,000 | +14.3% | 281 | +11.5% | 0.00% | – |
| Q2 2021 | $7,000 | +40.0% | 252 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +400.0% | 252 | +270.6% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 68 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 68 | -65.3% | 0.00% | – |
| Q1 2020 | $3,000 | – | 196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |